Jefferies is keeping their Buy rating on Caliper Life Sciences (NASDAQ: CALP) while they raise their price target on the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE